Select Medical Holdings Corporation (SEM) P/E Ratio History
Insufficient DataValuation data unavailable. · Data 2009–2026
Loading P/E history...
P/E Ratio Analysis
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SEM DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
SEM Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
SEM P/E vs Peers
Post-Acute & Senior Care peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $11B | 26.9 | 1.95 | +14% | |
| $12B | 7.9 | 0.49 | +37% | |
| $107B | 15.9 | 0.75 | +29% | |
| $24B | 7.9Lowest | 0.24Best | -53% | |
| $124B | 26.3 | - | +49%Best | |
| $64B | 34.8 | 1.23 | +12% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
SEM Historical P/E Data (2009–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $16.29 | $1.09 | 14.9x | +87% |
| FY2025 Q4 | Dec 31 2025 | $14.85 | $1.17 | 12.7x | +59% |
| FY2025 Q3 | - | $12.84 | $0.87 | 14.8x | +85% |
| FY2025 Q2 | Jun 30 2025 | $15.18 | $1.07 | 14.2x | +78% |
| FY2025 Q1 | Mar 31 2025 | $16.70 | $1.35 | 12.4x | +55% |
| FY2024 Q4 | - | $18.85 | $1.66 | 11.4x | +42% |
| FY2024 Q3 | Sep 30 2024 | $18.78 | $2.14 | 8.8x | +10% |
| FY2024 Q2 | Jun 30 2024 | $18.88 | $2.09 | 9.0x | +13% |
| FY2024 Q1 | Mar 31 2024 | $16.24 | $2.10 | 7.7x | -3% |
| FY2023 Q4 | Dec 31 2023 | $12.66 | $1.91 | 6.6x | -17% |
| FY2023 Q3 | Sep 30 2023 | $13.61 | $1.85 | 7.4x | -8% |
| FY2023 Q2 | Jun 30 2023 | $17.16 | $1.78 | 9.6x | +21% |
| FY2023 Q1 | Mar 31 2023 | $13.92 | $1.60 | 8.7x | +9% |
| FY2022 Q4 | Dec 31 2022 | $13.37 | $1.41 | 9.5x | +19% |
| FY2022 Q3 | Sep 30 2022 | $11.90 | $1.62 | 7.3x | -8% |
| FY2022 Q2 | - | $12.72 | $1.88 | 6.8x | -15% |
| FY2022 Q1 | - | $12.92 | $2.67 | 4.8x | -39% |
| FY2021 Q4 | Dec 31 2021 | $15.83 | $3.12 | 5.1x | -36% |
| FY2021 Q3 | - | $19.48 | $3.20 | 6.1x | -24% |
| FY2021 Q2 | Jun 30 2021 | $22.76 | $3.20 | 7.1x | -11% |
| FY2021 Q1 | Mar 31 2021 | $18.36 | $2.37 | 7.7x | -3% |
| FY2020 Q4 | - | $14.90 | $1.95 | 7.6x | -4% |
| FY2020 Q3 | Sep 30 2020 | $11.21 | $1.59 | 7.1x | -12% |
| FY2020 Q2 | - | $7.93 | $1.25 | 6.3x | -20% |
| FY2020 Q1 | - | $8.08 | $1.19 | 6.8x | -15% |
| FY2019 Q4 | - | $12.57 | $1.09 | 11.5x | +45% |
| FY2019 Q3 | Sep 30 2019 | $8.92 | $1.04 | 8.6x | +8% |
| FY2019 Q2 | Jun 30 2019 | $8.55 | $1.05 | 8.1x | +2% |
| FY2019 Q1 | Mar 31 2019 | $7.59 | $1.07 | 7.1x | -11% |
| FY2018 Q4 | Dec 31 2018 | $8.27 | $1.02 | 8.1x | +2% |
| FY2018 Q3 | Sep 30 2018 | $9.91 | $1.62 | 6.1x | -23% |
| FY2018 Q2 | Jun 30 2018 | $9.77 | $1.52 | 6.4x | -19% |
| FY2018 Q1 | Mar 31 2018 | $9.29 | $1.49 | 6.2x | -22% |
| FY2017 Q4 | Dec 31 2017 | $9.51 | $1.36 | 7.0x | -12% |
| FY2017 Q3 | Sep 30 2017 | $10.34 | $0.73 | 14.2x | +78% |
| FY2017 Q2 | Jun 30 2017 | $8.27 | $0.64 | 12.9x | +62% |
| FY2017 Q1 | Mar 31 2017 | $7.19 | $0.58 | 12.4x | +56% |
| FY2016 Q4 | Dec 31 2016 | $7.14 | $0.88 | 8.1x | +2% |
| FY2016 Q3 | Sep 30 2016 | $7.27 | $0.95 | 7.7x | -4% |
| FY2016 Q2 | - | $5.85 | $1.12 | 5.2x | -34% |
| FY2016 Q1 | - | $6.36 | $1.14 | 5.6x | -30% |
| FY2015 Q4 | - | $6.41 | $0.99 | 6.5x | -19% |
| FY2015 Q3 | Sep 30 2015 | $5.81 | $0.97 | 6.0x | -25% |
| FY2015 Q2 | - | $8.72 | $0.95 | 9.2x | +15% |
| FY2015 Q1 | - | $7.99 | $0.94 | 8.5x | +7% |
| FY2014 Q4 | Dec 31 2014 | $7.76 | $0.91 | 8.5x | +7% |
| FY2014 Q3 | - | $6.48 | $0.92 | 7.0x | -12% |
| FY2014 Q2 | Jun 30 2014 | $8.40 | $0.89 | 9.4x | +18% |
| FY2014 Q1 | Mar 31 2014 | $6.70 | $0.82 | 8.2x | +3% |
| FY2013 Q4 | - | $6.25 | $0.82 | 7.6x | -4% |
| FY2013 Q3 | Sep 30 2013 | $4.35 | $0.90 | 4.8x | -39% |
| FY2013 Q2 | Jun 30 2013 | $4.42 | $0.90 | 4.9x | -38% |
| FY2013 Q1 | Mar 31 2013 | $4.85 | $1.01 | 4.8x | -40% |
| FY2012 Q4 | Dec 31 2012 | $5.08 | $1.06 | 4.8x | -40% |
| FY2012 Q3 | Sep 30 2012 | $6.05 | $1.03 | 5.9x | -26% |
| FY2012 Q2 | Jun 30 2012 | $5.44 | $1.03 | 5.3x | -34% |
| FY2012 Q1 | Mar 31 2012 | $4.14 | $0.80 | 5.2x | -35% |
| FY2011 Q4 | Dec 31 2011 | $4.57 | $0.73 | 6.3x | -21% |
| FY2011 Q3 | Sep 30 2011 | $3.59 | $0.61 | 5.9x | -26% |
| FY2011 Q2 | - | $4.78 | $0.49 | 9.8x | +22% |
| FY2011 Q1 | - | $4.34 | $0.56 | 7.8x | -3% |
| FY2010 Q4 | Dec 31 2010 | $3.94 | $0.49 | 8.0x | +1% |
| FY2010 Q3 | - | $4.15 | $0.54 | 7.7x | -4% |
| FY2010 Q2 | Jun 30 2010 | $3.65 | $0.50 | 7.3x | -8% |
| FY2010 Q1 | Mar 31 2010 | $4.55 | $0.67 | 6.8x | -15% |
| FY2009 Q4 | - | $5.72 | $0.93 | 6.2x | -23% |
| FY2009 Q3 | Sep 30 2009 | $5.42 | $0.89 | 6.1x | -24% |
Average P/E for displayed period: 8.0x
SEM Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
17+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SEM — Frequently Asked Questions
Quick answers to the most common questions about buying SEM stock.
What is SEM's P/E ratio?
Select Medical Holdings Corporation (SEM) trailing twelve-month P/E ratio is N/A, based on TTM diluted EPS of N/A. The 5-year average P/E is 9.2x and the historical range spans 4.8x to 14.9x.
Is SEM stock overvalued or undervalued?
SEM current P/E: N/A. 5-year average P/E: 9.2x. Percentile: N/A.
Is SEM stock expensive?
SEM is fairly valued relative to its own history. The current P/E of N/A is near the 5-year average of 9.2x (N/A percentile of historical range).
What is SEM's historical P/E range?
Over the past 5 years, SEM's P/E ratio has ranged from 4.8x to 14.9x, with a median of 8.8x and an average of 9.2x. The current P/E of N/A places the stock at the N/A percentile of this range. Full historical data spans 2009–2026.
How does SEM's P/E compare to the S&P 500?
SEM current P/E: N/A. S&P 500 median P/E: 21.8x.
How does SEM's valuation compare to Healthcare peers?
Select Medical Holdings Corporation P/E of N/A can be benchmarked against Healthcare peers in the comparison table on this page.
What is SEM's PEG ratio?
SEM PEG ratio is N/A. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is SEM's earnings yield?
SEM earnings yield is N/A, the inverse of its N/A P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.